Author
Warren Ladiges
- Indexed works
- 25
- Total citations
- 2,863
- Active years
- 11
Collaborators
Works in the record
EBioMedicine 2018
Open access · CC-BY
Fisetin is a senotherapeutic that extends health and lifespan
Nature 2021
Preprint · OA
An aged immune system drives senescence and ageing of solid organs
JCI Insight 2020
Open access · CC-BY
Canagliflozin extends life span in genetically heterogeneous male but not female mice
Aging 2020
Preprint · CC-BY
ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging
Aging Cell 2017
Open access · CC-BY
Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans
Aging Cell 2009
Open access · OA
Lifespan extension in genetically modified mice
Aging Cell 2019
Open access · CC-BY
Glycine supplementation extends lifespan of male and female mice
GeroScience 2020
Open access · OA
Heterochronic parabiosis regulates the extent of cellular senescence in multiple tissues
Ageing Research Reviews 2016
Preprint · OA
Molecular pathology endpoints useful for aging studies
GeroScience 2019
Open access · OA
Validation of a geropathology grading system for aging mouse studies
GeroScience 2022
Open access · CC-BY
Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice
Cell Cycle 2013
Open access · OA
Chronic rapamycin treatment or lack ofS6K1does not reduce ribosome activity in vivo
Scientific Reports 2022
Open access · CC-BY
Reduced expression of mitochondrial complex I subunit Ndufs2 does not impact healthspan in mice
Scientific Reports 2022
Open access · CC-BY
Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate delays aging phenotypes in mice
GeroScience 2024
Open access · CC-BY
A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · OA
Canagliflozin Extends Lifespan in Genetically Heterogeneous Male But Not Female Mice
Aging Pathobiology and Therapeutics 2019
Open access · CC-BY
The rationale for testing drug combinations in aging intervention studies
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
A drug cocktail of rapamycin, acarbose, and phenylbutyrate enhances resilience to features of early-stage Alzheimer’s disease in aging mice
Aging Pathobiology and Therapeutics 2021
Open access · CC-BY
Physical performance is enhanced in old mice fed a short term diet medicated with rapamycin, acarbose, and phenylbutyrate
Aging Pathobiology and Therapeutics 2022
Open access · CC-BY
Pharmaceutical interventions to slow human aging. Are we ready for cocktails?
Aging Pathobiology and Therapeutics 2021
Open access · CC-BY
The antidiabetic drug acarbose suppresses age-related lesions in C57BL/6 mice in an organ dependent manner
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY
A cocktail of rapamycin, acarbose and phenylbutyrate prevents age-related cognitive decline in mice by altering aging pathways
Scientific Reports 2026
Open access · CC-BY
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · CC-BY
Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate slows aging in mice
Research Square 2026
Preprint · CC-BY